Radkowski Christopher MD Mc Keesport, PA - 15132

Radkowski Christopher MD is categorized under Internal Medicine Doctors in Mc Keesport, PA and active since 2010.

Radkowski Christopher MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Radkowski at the company’s single location by writing to 1321 5th Avenue # 1, Mc Keesport, Pennsylvania PA 15132 or by phoning (412) 678-0534. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Radkowski Christopher MD
Contact Person: Christopher Radkowski
Address: 1321 5th Avenue # 1, Mc Keesport, Pennsylvania 15132
Phone Number: (412) 678-0534
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Radkowski Christopher MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Christopher Radkowski for inquiries that concern Radkowski Christopher MD by calling the company number (412) 678-0534, as your correspondence is most welcome. Additionally, the physical location of the single location of Radkowski Christopher MD can be found at the coordinates 40.35209,-79.85125 as well as the street address 1321 5th Avenue # 1 in Mc Keesport, Pennsylvania 15132.

For its online presence, you may visit Radkowski Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.